Table 2.

Subgroup analysis of admission mortality. SSc disease characteristics are based on the Medsger severity scale classification12. Data in bold face are statistically significant.

DemographicsDeath (%) Patients, n = 6No Death (%) Patients, n = 31p
  Sex3 male4 male0.014
  Age62 ± 1258.5 ± 130.52
  Race4 AA, 2 W10 AA, 21 W0.169
Disease characteristicsCases, n = 6Cases, n = 58 (%)
  Raynaud phenomenon337 (64)0.663
  Digital ulcers213 (22)0.621
  Interstitial lung disease215 (26)0.652
  Pulmonary arterial hypertension224 (41)1
  Esophageal involvement042 (72)0.001
  Gastric involvement017 (29)0.181
  Bacterial overgrowth09 (16)0.581
  Opioids (on admission)29 (16)0.278
  Promotility (on admission)429 (50)0.673
Symptoms
  Diarrhea09 (16)0.579
  Abdominal pain028 (48)0.031
  Nausea345 (77)0.159
  Weight loss19 (16)1
  Hematochezia01 (2)1
  Melena02 (3)1
  Fever04 (7)1
Laboratory values
  Hemoglobin9.9 ± 0.612 ± 2.10.00008
  White blood cell count11.2 ± 4.410.7 ± 5.80.831
  AST42 ± 4836 ± 260.799
  ALT18 ± 6.433 ± 350.018
  Total bilirubin0.6 ± 0.050.78 ± 1.10.454
  ALP68 ± 33124 ± 750.013
  Creatinine1.8 ± 1.81 ± 0.50.405
  Albumin2.5 ± 0.53.7 ± 0.90.001
  Lipase17 ± 8.586 ± 1990.058
  Amylase71 ± 21110 ± 660.03
Treatment modality
  NPO442 (72)0.629
  Surgery23 (5)0.065
  Nasogastric tube620 (34)0.003
  Prokinetic427 (47)0.419
  Antibiotics119 (33)0.653
  Intravenous fluids338 (66)0.658
  Total parenteral nutrition121 (36)0.655
Outcome
  Spontaneous resolution045 (76)0.0004
  Prolonged TPN016 (27)0.0001
  Days hospitalized27 ± 2110.1 ± 9.90.098
  • SSc: systemic sclerosis; AA: African American; W: white; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; NPO: nil per os; TPN: total parenteral nutrition.